Lumobiotics

Description: Lumobiotics develops light-controllable peptide drugs for targeted cancer & infection treatment, minimizing side effects with precise light activation.

Country: Germany

Based in: Karlsruhe

Founded: 2017

Funding Stage: Series A/B

Tags: ['Biotechnology', 'Health Care', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.